Multinational Pharmaceutical Company A's Development Strategy In China

In the development of today,which as global information network and global economic integration are becoming increasingly fierce,multinational companies need to obtain greater development and profit,Chinese market share is definitely an important part.Broad market and good investment environment be attracted by global multinational pharmaceutical companies,China pharmaceutical market has great potentiality,the development speed will be as 15% ~ 20% increasing in the next five years,according to the analysis of the forecast,China pharmaceutical market in 2020 will reach $120 billion then based on the big scale to become the world's largest market even beyond the United States.July 22,2015,Fortune Magazine announced Top 500 Global corporations in 2015.And total of 13 medical companies on that Fortune list,10 companies belongs to pharmaceutical industry.China markets was treat by Multi-National Corporations as an integral component in global division system,China market also to follow as a matter of course to become the basic strategy of investment.Under the condition of increasing change environment in China,products generation gap status of Multinational Pharmaceutical Companies' affected by the great influence of drug price,bidding policy,and together with China's overall economic slowdown,both internal and external factors integrated then result the Multinational Pharmaceutical Companies have to thought their business directly from "the best time" slip to "the worst time".So we have the necessary to investigate the development trend of Multinational Pharmaceutical Companies and the current development strategy in China.Under the influence of medical reform policy recent years,Multinational Pharmaceutical Companies have to start three or four tier of urban development,but lots of difficulties and challenges were encountered.In this thesis,SWOT analysis method was used,advantages,disadvantages,opportunities and threats were analyzed of Multinational Pharmaceutical Company A.in addition,PEST analysis method was used to analyze external macro environment factors of this company,make analysis on politics,economy and technology as well as society,which as the four mainly influent external environmental factors.Directly aim at problems which encountered in the actual layout of three or four lines cities,one by one analysis,eventually the possible ways and measures of the multinational pharmaceutical Company were obtained,according to the establishment of an independent business operation to respond flexibly of the policy changes,and price cuts to improve sales,sustained to improve and strengthen the existing service consciousness and the development of other ancillary services and products,as well as the charity activities help to enhance corporate social responsibility sense,and to obtain the conviction of the whole society.Due to Multinational Pharmaceutical Companies in China usually occupy the second and third level hospital of first and second tier cities,late to start the occupation of the three or four tier cities layout,so it's still in immature development at present.The research results draw from this thesis is not only for the specific multinational pharmaceutical company in three or four tier city layout to have a big practical significance but also can be reference by other multinational pharmaceutical companies,even have the meaning of referential significance for advanced domestic pharmaceutical companies to set up the strategic planning of the three or four tier cities layout.